Articles dans des revues avec comité de lecture (16)
13.
Dixit, M., Ansseau, E., Tassin, A., Winokur, S., Shi, R., Qian, H., Sauvage, S., Matteotti, C., Van Acker, A. M., Leo, O., Figlewicz, D., Barro, M., Laoudj-Chenivesse, D., Belayew, A., Coppee, F., & Chen, Y.-W. (2007). DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proceedings of the National Academy of Sciences of the United States of America, 104(46), 18157-18162. doi:10.1073/pnas.070865910414.
Mathieu, V., Le Mercier, M., De Nève, N., Sauvage, S., Gras, T., Roland, I., Lefranc, F., & Kiss, R. (2007). Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model. Journal of investigative dermatology, 127(10), 2399-2410. doi:10.1038/sj.jid.570086915.
Kowaljow, V., Marcowycz, A., Ansseau, E., Conde, C. B., Sauvage, S., Matteotti, C., Arias, C., Corona, E. D., Nuñez, N. G., Leo, O., Wattiez, R., Figlewicz, D., Laoudj-Chenivesse, D., Belayew, A., Coppee, F., & Rosa, A. L. (2007). The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscular disorders, 17(8), 611-623. doi:10.1016/j.nmd.2007.04.00216.
Van Quaquebeke, E., Mahieu, T., Dumont, P., Dewelle, J., Ribaucour, F., Simon, G., Sauvage, S., Gaussin, J.-F., Tuti, J., El Yazidi, M., Van Vynckt, F., Mijatovic, T., Lefranc, F., Darro, F., & Kiss, R. (2007). 2,2,2-Trichloro-N-({2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin- 5-yl}carbamoyl)acetamide (UNBS3157), a novel nonhematotoxic naphthalimide derivative with potent antitumor activity. Journal of medicinal chemistry, 50(17), 4122-4134. doi:10.1021/jm070315q Participations à des congrès et colloques internationaux (5)
1.
Trepant, A.-L., Maris, C., D'Haene, N., Sauvage, S., Rorive, S., Decaestecker, C., Salmon, I., & Demetter, P. (2015). Role of IGFIIR/Man-6-P in Glioblastoma angiogenesis. Dublin Pathology 2015: Plenary Oral and Oral Abstracts (p. 7) Abstract session presented at Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland(8 th: 23 – 25 June 2015: Dublin).2.
Trepant, A.-L., Bouchart, C., Rorive, S., Sauvage, S., Decaestecker, C., Demetter, P., & Salmon, I. (2014). Identification of OLIG2 as most specific glioblastoma stem cell marker starting from comparative analysis of data from similar DNA chip microarray platforms. International Journal Of Molecular Medicine. Vol. 34 (pp. S43-S43) Abstract session presented at 19th World Congress on Advances in Oncology and 17th International Symposium on Molecular Medecine(October 9-11, 2014: Athens).3.
Verset, L., Sauvage, S., Tommelein, J., Moles Lopez, X., Decaestecker, C., Mareel, M., Bracke, M., Salmon, I., De Wever, O., & Demetter, P. (2014). ADAM-17/FHL2 Colocalisation Suggests Interaction and Role of These Proteins in Colorectal Cancer. Paper session presented at Belgian week of gastroenterology (XXVIth Edition: 12/02/2014: Dolce la Hulpe).4.
D'Haene, N., Sauvage, S., Maris, C., Trepant, A.-L., Le Mercier, M., Decaestecker, C., & Salmon, I. (2011). Involvement of Vascular Endothelial Growth Factor Receptors in Endothelial Cell Response to Galectin-1 and Galectin-3. Journal Of Pathology: Ghent Pathology 2011. Vol. Volume 224, Issue S2 (pp. S15-S16) Abstract session presented at 6th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland(May 2011).5.
Lefranc, F., Ingrassia, L., Sauvage, S., Gaussin, J.-F., Dewelle, J., & Kiss, R. (2009). Narciclasine, a plant growth modulator with potent anti-tumor effects in experimental glioblastomas. Poster présenté à la conférence American Association for Cancer Research Annual Meeting (100th: April: Denver - CO - USA).